Curative Biotechnology, Inc.
(Note: Curative Biotechnology, Inc. withdrew its plans for an NYSE-American uplisting/public offering in an SEC filing dated Jan. 31, 2024. The prospectus was filed on Nov. 7, 2022.) (Note: This is NOT an IPO. There was some expectation that the public offering (NYSE-American uplisting) would price on Jan. 30, 2023, but no pricing announcement was […]
October 2, 2022 Read More